Protopam Chloride
NDC 60977-141, pralidoxime chloride, injection, powder, lyophilized, for solution, from Baxter Healthcare Corporation.
- Product NDC
- 60977-141
- Status
- Listed
- Labeler
- Baxter Healthcare Corporation
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA014134
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60977-141 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PRALIDOXIME CHLORIDE1 g/20mL
Pharmacologic classes
Cholinesterase Reactivator [EPC]; Cholinesterase Reactivators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60977-141-01 | 60977014101 | 6 VIAL, SINGLE-DOSE in 1 PACKAGE (60977-141-01) / 20 mL in 1 VIAL, SINGLE-DOSE (60977-141-27) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2741d8fd-51c2-46be-880b-99f2b20a6137
Use it
Look up 60977-141 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60977-141 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60977-141. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.